José Bueno-Lledó
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
José Bueno-Lledó has a total of 266 co-authors. Here are the top co-authors by number of shared publications:
Providencia García Pastor
Unidad de Cirugía de Pared Abdominal y Corta Estancia, Hospital Politécnico y Universitario La Fe, Valencia, España
9 shared publicationsFernando Carbonell Tatay
Instituto Valenciano de Oncología, Valencia, España
7 shared publicationsSalvador Pous-Serrano
Unit of Abdominal Wall Surgery, Department of Digestive Surgery, Hospital Universitari i Politecnic “La Fe”, University of Valencia, Valencia, Spain
7 shared publicationsAntonio Torregrosa-Gallud
La Fe
6 shared publicationsJavier Vaqué Urbaneja
6 shared publications- M. Planells Roig
Instituto de Cirugía General y del Aparato Digestivo (ICAD)
6 shared publications
Latest Publications
- Open Access
- 20 August 2026
- Published by Frontiers Media SA in Frontiers in Surgery
- Vol. 13, 1961336
Editorial: Biosynthetic resorbable meshes: a New frontier in abdominal wall hernia repair
Long-term absorbable biosynthetic meshes (LTABMs) have become a relevant addition to the armamentarium of abdominal wall surgeons, due to their practical position as a compromise between biologic scaffolds and permanent synthetics. Their appeal lies in the possibility of providing temporary mechanical support during the critical phases of wound healing while avoiding a lifelong implanted foreign body. For abdominal wall surgeons facing increasingly complex patients, this concept is intuitively attractive and clinically consequential.Obesity, diabetes, smoking, prior mesh infection, stomas, multiple laparotomies, immunosuppression, and contamination have transformed hernia surgery into a field where the biological environment is as important as the fascial defect itself (1). In these settings, the traditional binary choice between permanent synthetic and biologic mesh has often proven unsatisfactory. Permanent synthetics offer strength and durability, but concerns persist regarding chronic infection, fistulization, pain, and the consequences of an implanted material that cannot be removed easily once incorporated. Biologic meshes, in contrast, were introduced as a solution for contaminated or high-risk fields, yet long-term durability has been inconsistent and their cost remains a major obstacle to routine use (2).Several properties explain the growing interest in LTABMs. First, they offer a prolonged strengthretention profile intended to protect the repair through the biologically vulnerable phases of healing. The P4HB literature describes a scaffold with flexibility, handling characteristics, and durability that make it suitable for ventral and incisional hernia repair, while allowing eventual degradation into naturally occurring metabolites (3). Second, these meshes appear to support constructive remodeling rather than merely passive scar encapsulation. Preclinical data summarized in recent reviews show collagen deposition, vascular ingrowth, and progressive replacement of scaffold material by host tissue, with the hope that the final repair will depend more on biologically integrated tissue than on a permanent prosthesis. Third, the inflammatory profile may differ from that of conventional permanent synthetics. Experimental work has suggested a host response compatible with tissue remodeling and less persistent inflammatory activity than some traditional materials, although direct clinical translation remains difficult because comparative human histologic data are limited (4).The strongest clinical argument for these meshes is their use in the gray zone of abdominal wall reconstruction. In a straightforward clean retromuscular repair of a low-risk patient, permanent synthetic mesh remains an efficient and durable option with a strong track record. The value of these prostheses becomes more evident when the field is less ideal, the host is less forgiving, or the consequences of a permanent implant are potentially greater. This includes patients with prior wound events, a history of mesh infection, concomitant stoma, immunosuppression, obesity, diabetes, smoking, or a clean-contaminated or contaminated operative field (5).Available clinical studies support this selective enthusiasm more than any universal recommendation. A recent scoping review identified 79 peer-reviewed studies, including 50 clinical studies, and reported promising outcomes across hernia repair and soft tissue reconstruction, while also emphasizing the need for randomized trials and better definition of indications (6). These data suggest that the field has progressed beyond anecdotal experience,but not yet to definitive evidence.Long-term follow-up is particularly important because a mesh that disappears must ultimately be judged after it is gone. In clean wound ventral hernia repair, long-term outcomes with LTABMs have been reported as acceptable, with recurrence rates up to 20% after 3-5 years follow-up in patients at higher risk (grade 2 and 3 VHWG). In one long-term series of complex abdominal wall reconstruction comparing absorbable scaffold with porcine cadaveric mesh, the absorbable mesh demonstrated better durability over five years, reinforcing the notion that a biosynthetic repair can remain intact beyond the resorption period (7).The growing literature should not obscure the field's limitations. Most available studies are retrospective, industry-linked, single-arm, or based on heterogeneous populations that mix primary and incisional hernias, variable mesh planes, different component separation strategies, and broad contamination categories. Cost remains an additional challenge. LTABMs are generally less expensive than biologic matrices, which has supported their uptake as a costconscious alternative in complex reconstructions (8). However, they are usually still more expensive than standard permanent synthetics, so their value proposition depends on the clinical context, the probability of contamination-related morbidity, and the surgeon's estimate of the burden imposed by a permanent device. In health systems increasingly attentive to value-based care, these distinctions matter.Patient selection is equally decisive. LTABMs are most compelling when the surgeon seeks reinforcement but wishes to avoid leaving permanent synthetic material in a field with elevated infection risk or uncertain tissue behavior (9). That does not mean it should replace permanent mesh in all moderate-risk patients, nor that it should be viewed as a surrogate for meticulous technique. Rather, it is best understood as a strategic material for selected reconstructions in which a temporary scaffold may align more closely with the biological reality of the operation.LTABMs deserve a firm place in the contemporary discussion of abdominal wall surgery because they answer a clinically relevant question: can a repair be reinforced long enough to heal without committing the patient to a permanent prosthesis? The accumulated evidence...
- 20 August 2026
- Published by Frontiers Media SA in Frontiers in Surgery
- Vol. 13, 1961336
Open AccessEditorial: Biosynthetic resorbable meshes: a New frontier in abdominal wall hernia repair
Long-term absorbable biosynthetic meshes (LTABMs) have become a relevant addition to the armamentarium of abdominal wall surgeons, due to their practical position as a compromise between biologic scaffolds and permanent synthetics. Their appeal lies in the possibility of providing temporary mechanical support during the critical phases of wound healing while avoiding a lifelong implanted foreign body. For abdominal wall surgeons facing increasingly complex patients, this concept is intuitively attractive and clinically consequential.Obesity, diabetes, smoking, prior mesh infection, stomas, multiple laparotomies, immunosuppression, and contamination have transformed hernia surgery into a field where the biological environment is as important as the fascial defect itself (1). In these settings, the traditional binary choice between permanent synthetic and biologic mesh has often proven unsatisfactory. Permanent synthetics offer strength and durability, but concerns persist regarding chronic infection, fistulization, pain, and the consequences of an implanted material that cannot be removed easily once incorporated. Biologic meshes, in contrast, were introduced as a solution for contaminated or high-risk fields, yet long-term durability has been inconsistent and their cost remains a major obstacle to routine use (2).Several properties explain the growing interest in LTABMs. First, they offer a prolonged strengthretention profile intended to protect the repair through the biologically vulnerable phases of healing. The P4HB literature describes a scaffold with flexibility, handling characteristics, and durability that make it suitable for ventral and incisional hernia repair, while allowing eventual degradation into naturally occurring metabolites (3). Second, these meshes appear to support constructive remodeling rather than merely passive scar encapsulation. Preclinical data summarized in recent reviews show collagen deposition, vascular ingrowth, and progressive replacement of scaffold material by host tissue, with the hope that the final repair will depend more on biologically integrated tissue than on a permanent prosthesis. Third, the inflammatory profile may differ from that of conventional permanent synthetics. Experimental work has suggested a host response compatible with tissue remodeling and less persistent inflammatory activity than some traditional materials, although direct clinical translation remains difficult because comparative human histologic data are limited (4).The strongest clinical argument for these meshes is their use in the gray zone of abdominal wall reconstruction. In a straightforward clean retromuscular repair of a low-risk patient, permanent synthetic mesh remains an efficient and durable option with a strong track record. The value of these prostheses becomes more evident when the field is less ideal, the host is less forgiving, or the consequences of a permanent implant are potentially greater. This includes patients with prior wound events, a history of mesh infection, concomitant stoma, immunosuppression, obesity, diabetes, smoking, or a clean-contaminated or contaminated operative field (5).Available clinical studies support this selective enthusiasm more than any universal recommendation. A recent scoping review identified 79 peer-reviewed studies, including 50 clinical studies, and reported promising outcomes across hernia repair and soft tissue reconstruction, while also emphasizing the need for randomized trials and better definition of indications (6). These data suggest that the field has progressed beyond anecdotal experience,but not yet to definitive evidence.Long-term follow-up is particularly important because a mesh that disappears must ultimately be judged after it is gone. In clean wound ventral hernia repair, long-term outcomes with LTABMs have been reported as acceptable, with recurrence rates up to 20% after 3-5 years follow-up in patients at higher risk (grade 2 and 3 VHWG). In one long-term series of complex abdominal wall reconstruction comparing absorbable scaffold with porcine cadaveric mesh, the absorbable mesh demonstrated better durability over five years, reinforcing the notion that a biosynthetic repair can remain intact beyond the resorption period (7).The growing literature should not obscure the field's limitations. Most available studies are retrospective, industry-linked, single-arm, or based on heterogeneous populations that mix primary and incisional hernias, variable mesh planes, different component separation strategies, and broad contamination categories. Cost remains an additional challenge. LTABMs are generally less expensive than biologic matrices, which has supported their uptake as a costconscious alternative in complex reconstructions (8). However, they are usually still more expensive than standard permanent synthetics, so their value proposition depends on the clinical context, the probability of contamination-related morbidity, and the surgeon's estimate of the burden imposed by a permanent device. In health systems increasingly attentive to value-based care, these distinctions matter.Patient selection is equally decisive. LTABMs are most compelling when the surgeon seeks reinforcement but wishes to avoid leaving permanent synthetic material in a field with elevated infection risk or uncertain tissue behavior (9). That does not mean it should replace permanent mesh in all moderate-risk patients, nor that it should be viewed as a surrogate for meticulous technique. Rather, it is best understood as a strategic material for selected reconstructions in which a temporary scaffold may align more closely with the biological reality of the operation.LTABMs deserve a firm place in the contemporary discussion of abdominal wall surgery because they answer a clinically relevant question: can a repair be reinforced long enough to heal without committing the patient to a permanent prosthesis? The accumulated evidence...
- 6 March 2026
- Published by Springer Nature in Hernia
- Vol. 30 (1) , 115
A practical algorithm for the management of mesh infection in abdominal wall surgery: learnings after 20 years of experience
- 6 March 2026
- Published by Springer Nature in Hernia
- Vol. 30 (1) , 115
A practical algorithm for the management of mesh infection in abdominal wall surgery: learnings after 20 years of experience
- 27 January 2026
- Published by Springer Nature in Hernia
- Vol. 30 (1) , 75
Ultrasound alone is sufficient: no added value of electromyography in botulinum toxin prehabilitation for complex ventral hernias?
- 27 January 2026
- Published by Springer Nature in Hernia
- Vol. 30 (1) , 75
Ultrasound alone is sufficient: no added value of electromyography in botulinum toxin prehabilitation for complex ventral hernias?
- Open Access
- 6 October 2025
- Published by Wiley in International Wound Journal
- Vol. 22 (10) , e70750
Closed‐Incision Negative Pressure Therapy: Scoping Review and Multidisciplinary Consensus Recommendations of the Spanish Observatory of Infection in Surgery
Surgical site infections (SSI) and surgical site complications (SSC) significantly impact surgery outcomes, increasing hospital stays and mortality rates, and negatively affecting patients' quality of life. Closed‐incision negative pressure therapy (ciNPT) emerged as a prophylactic strategy to reduce these complications. However, its applicability across different surgical procedures remains unclear. A scoping review was conducted to synthesise the available evidence on the use of ciNPT in different surgical contexts. A multidisciplinary panel of experts from different surgical specialties was assembled to identify patient risk factors for SSCs specific to each modality. Surgical procedures were categorised based on anticipated SSC rates and the impact of SSI. A decision diagram was finally developed, providing tailored recommendations for ciNPT use according to individual surgical circumstances. The findings of the review indicate that ciNPT effectively reduces SSI and SSC in most surgical procedures. Key patient‐related factors influencing outcomes, such as age, obesity, and malnutrition, were outlined. Additionally, a specialty‐based list of surgical procedures was compiled, specifying whether ciNPT is recommended, not recommended, or conditionally recommended based on specific criteria. This study underscores the benefits of ciNPT and provides a comprehensive guide to its application across several surgical specialties, aiming to optimise patient management and inform clinical practise.
- 6 October 2025
- Published by Wiley in International Wound Journal
- Vol. 22 (10) , e70750
Open AccessClosed‐Incision Negative Pressure Therapy: Scoping Review and Multidisciplinary Consensus Recommendations of the Spanish Observatory of Infection in Surgery
Surgical site infections (SSI) and surgical site complications (SSC) significantly impact surgery outcomes, increasing hospital stays and mortality rates, and negatively affecting patients' quality of life. Closed‐incision negative pressure therapy (ciNPT) emerged as a prophylactic strategy to reduce these complications. However, its applicability across different surgical procedures remains unclear. A scoping review was conducted to synthesise the available evidence on the use of ciNPT in different surgical contexts. A multidisciplinary panel of experts from different surgical specialties was assembled to identify patient risk factors for SSCs specific to each modality. Surgical procedures were categorised based on anticipated SSC rates and the impact of SSI. A decision diagram was finally developed, providing tailored recommendations for ciNPT use according to individual surgical circumstances. The findings of the review indicate that ciNPT effectively reduces SSI and SSC in most surgical procedures. Key patient‐related factors influencing outcomes, such as age, obesity, and malnutrition, were outlined. Additionally, a specialty‐based list of surgical procedures was compiled, specifying whether ciNPT is recommended, not recommended, or conditionally recommended based on specific criteria. This study underscores the benefits of ciNPT and provides a comprehensive guide to its application across several surgical specialties, aiming to optimise patient management and inform clinical practise.
- 3 September 2025
- Published by Springer Nature in Hernia
- Vol. 29 (1) , 1-10
Analysis of polypropylene meshes with embedded silver ions in ventral hernia repair: can they be used in different grades of contamination?
Background This study aimed to analyze the outcomes of patients undergoing ventral hernia repair (VHR) with a polypropylene mesh with embedded silver ions (PSM) in the context of different degrees of contamination, compared to standard conventional macroporous polypropylene mesh (PPL). Methods From May 2019 to October 2023, a retrospective comparative analysis of patients who underwent elective or urgent VHR with a SilverMesh (PSM group) versus standard macroporous polypropylene mesh (PPL group), based on the Spanish Hernia registry (EVEREG). The exclusion criteria were other PSM indications (groin hernia, prophylaxis) and the use of composite meshes or any material different to PPL. Each Hospital participating in the registry applied its own preoperative antibiotic protocol. The field contamination degree was assessed according the Centers for Disease Control (CDC) classification criteria. Epidemiological data, hernia characteristics, surgical and postoperative variables (Clavien-Dindo classification) of these patients were analysed. Results From May 2019 to October 2023, PPL group included 446 cases and PSM group 206 cases. The number of PPL cases were reduced from 2655 to 446, to try and match suitable similar cases in both groups. In PSM group, smoking (28.6% vs. 20.6%; p = 0.000), COPD (23.3% vs. 16.9%; p = 0.050), ASA class III-IV (35% vs. 29.2%; p = 0.001), prehabilitation with BTA (16% vs. 4%; p = 0.000) and PPP (5.8% vs. 0.9%; p = 0.000), and W2-W3 hernias (79.9% vs. 53.2%; p = 0.000) were more frequent than PPL group. In PSM group, complex techniques of VHR like RSR and CST (61% vs. 48%; p = 0.000), average duration of surgery (91.7 vs. 69.9 min; p = 0.032) and mean length of stay (5.4 vs. 4.7 days; p = 0.034) were more frequent than PPL group. The overall rate of short-term SSO was slightly lower in PSM than PPL group (30.5% vs. 33.7%; p = 0.155) though statistically insignificant. No mesh infection was reported in PSM group versus 7 cases in PPL group, although this was not statistically significant. Conclusions The use of PSM for VHR in different degrees of contamination and without a significant superiority over PPL, leads to favourable results, especially in overall rate of SSO and CMI, in patients with preoperative risk factors, large hernias and complex hernia repairs. Being the first clinical study performed with this prosthesis, further comparative studies with longer follow-up are needed to explore further.
- 3 September 2025
- Published by Springer Nature in Hernia
- Vol. 29 (1) , 1-10
Analysis of polypropylene meshes with embedded silver ions in ventral hernia repair: can they be used in different grades of contamination?
Background This study aimed to analyze the outcomes of patients undergoing ventral hernia repair (VHR) with a polypropylene mesh with embedded silver ions (PSM) in the context of different degrees of contamination, compared to standard conventional macroporous polypropylene mesh (PPL). Methods From May 2019 to October 2023, a retrospective comparative analysis of patients who underwent elective or urgent VHR with a SilverMesh (PSM group) versus standard macroporous polypropylene mesh (PPL group), based on the Spanish Hernia registry (EVEREG). The exclusion criteria were other PSM indications (groin hernia, prophylaxis) and the use of composite meshes or any material different to PPL. Each Hospital participating in the registry applied its own preoperative antibiotic protocol. The field contamination degree was assessed according the Centers for Disease Control (CDC) classification criteria. Epidemiological data, hernia characteristics, surgical and postoperative variables (Clavien-Dindo classification) of these patients were analysed. Results From May 2019 to October 2023, PPL group included 446 cases and PSM group 206 cases. The number of PPL cases were reduced from 2655 to 446, to try and match suitable similar cases in both groups. In PSM group, smoking (28.6% vs. 20.6%; p = 0.000), COPD (23.3% vs. 16.9%; p = 0.050), ASA class III-IV (35% vs. 29.2%; p = 0.001), prehabilitation with BTA (16% vs. 4%; p = 0.000) and PPP (5.8% vs. 0.9%; p = 0.000), and W2-W3 hernias (79.9% vs. 53.2%; p = 0.000) were more frequent than PPL group. In PSM group, complex techniques of VHR like RSR and CST (61% vs. 48%; p = 0.000), average duration of surgery (91.7 vs. 69.9 min; p = 0.032) and mean length of stay (5.4 vs. 4.7 days; p = 0.034) were more frequent than PPL group. The overall rate of short-term SSO was slightly lower in PSM than PPL group (30.5% vs. 33.7%; p = 0.155) though statistically insignificant. No mesh infection was reported in PSM group versus 7 cases in PPL group, although this was not statistically significant. Conclusions The use of PSM for VHR in different degrees of contamination and without a significant superiority over PPL, leads to favourable results, especially in overall rate of SSO and CMI, in patients with preoperative risk factors, large hernias and complex hernia repairs. Being the first clinical study performed with this prosthesis, further comparative studies with longer follow-up are needed to explore further.
- 28 August 2025
- Published by Springer Nature
- p. 429-442
Negative Pressure Therapies in Hernia Surgery
- 5 June 2025
- Published by Springer Nature in Hernia
- Vol. 29 (1) , 1-7
How can we predict or prevent late mesh infection in ventral hernia repair?
Background Mesh infection (CMI) after ventral hernia repair (VHR) is uncommon, with an incidence of 1–7%. The aim of this observational retrospective study was (1) to analyse the incidence and aetiologies of late CMI (one or more years after prosthetic repair) in a series of VHR patients, (2) to identify pre-operative and perioperative variables related to late CMI and (3) to consider possible prevention measures to reduce its occurrence. Materials and methods A multivariate analysis of a prospective database of patients with a diagnosis of CMI who underwent open VHR between January 2014 and December 2023 at a tertiary centre was conducted. Institutional review board approval was obtained. Two groups of patients were compared: patients with onset of CMI less than one year after VHR (early CMI [ECMI] group) and patients with onset of CMI (sinus or suspected infection) one or more years after VHR (late CMI [LCMI] group). Results At a median of 31.6 months (range: 19–55 months) of post-operative followup, 108 cases of CMI were reported, of which 64 cases were clinically diagnosed within one year of VHR (ECMI group) and 44 cases after one year (LCMI group). The most frequent clinical presentation of CMI was post-operative chronic sinus (94%) and mesh extrusion through the wound (6%). In multivariate analysis, pre-operative predictors associated with LCMI were BMI > 30 (p < 0.001; OR 1.980, p=0.002) and steroid or immunosuppressive drug use (p < 0.001; OR 1.06, p=0.004). Previous hernia repair using PTFE mesh was also a predictor of LCMI (p < 0.002; OR 2.11, p=0.000). Various factors, such as smoking, diabetes, previous hernia repair, presence of a stoma, operative time, concomitant enterotomy or post-operative SSI, were not significant indicators of LCMI. Conclusions CMI is one of the most prevalent and challenging complications of VHR. Obesity (BMI > 30) and immunosuppression, as well as the use of ePTFE mesh in the previous hernia repair, are predictors of LCMI after VHR; studies of these factors may reduce and prevent the occurrence of LCMI.
- 5 June 2025
- Published by Springer Nature in Hernia
- Vol. 29 (1) , 1-7
How can we predict or prevent late mesh infection in ventral hernia repair?
Background Mesh infection (CMI) after ventral hernia repair (VHR) is uncommon, with an incidence of 1–7%. The aim of this observational retrospective study was (1) to analyse the incidence and aetiologies of late CMI (one or more years after prosthetic repair) in a series of VHR patients, (2) to identify pre-operative and perioperative variables related to late CMI and (3) to consider possible prevention measures to reduce its occurrence. Materials and methods A multivariate analysis of a prospective database of patients with a diagnosis of CMI who underwent open VHR between January 2014 and December 2023 at a tertiary centre was conducted. Institutional review board approval was obtained. Two groups of patients were compared: patients with onset of CMI less than one year after VHR (early CMI [ECMI] group) and patients with onset of CMI (sinus or suspected infection) one or more years after VHR (late CMI [LCMI] group). Results At a median of 31.6 months (range: 19–55 months) of post-operative followup, 108 cases of CMI were reported, of which 64 cases were clinically diagnosed within one year of VHR (ECMI group) and 44 cases after one year (LCMI group). The most frequent clinical presentation of CMI was post-operative chronic sinus (94%) and mesh extrusion through the wound (6%). In multivariate analysis, pre-operative predictors associated with LCMI were BMI > 30 (p < 0.001; OR 1.980, p=0.002) and steroid or immunosuppressive drug use (p < 0.001; OR 1.06, p=0.004). Previous hernia repair using PTFE mesh was also a predictor of LCMI (p < 0.002; OR 2.11, p=0.000). Various factors, such as smoking, diabetes, previous hernia repair, presence of a stoma, operative time, concomitant enterotomy or post-operative SSI, were not significant indicators of LCMI. Conclusions CMI is one of the most prevalent and challenging complications of VHR. Obesity (BMI > 30) and immunosuppression, as well as the use of ePTFE mesh in the previous hernia repair, are predictors of LCMI after VHR; studies of these factors may reduce and prevent the occurrence of LCMI.
- 5 June 2024
- Published by Springer Nature in Hernia
- Vol. 28 (4) , 1427-1439
Chronic inguinal pain post-hernioplasty. Laparo-endoscopic surgery vs lichtenstein repair: systematic review and meta-analysis
Purpose Annually, over 20 million patients worldwide undergo inguinal hernia repair procedures. Surgery stands as the recommended treatment, however, a consensus on the optimal method is lacking. This study aims to conduct an updated systematic review and meta-analysis to compare the risk of chronic inguinal pain and recurrence between laparo-endoscopic mesh repair (TAPP and TEP) versus Lichtenstein repair for inguinal hernia. Methods Searches were conducted in Ovid MEDLINE, PubMed, EBSCO, Cochrane, and Google Scholar. Inclusion criteria encompassed randomized controlled trials (RCTs) involving adults, published in English and Spanish, comparing surgical outcomes among the Lichtenstein open technique, TAPP, and/or TEP. Adherence to the PRISMA guidelines was maintained in the methodology, and the CASP tool was employed to assess the quality of the articles. Statistical analysis involved mean [± standard deviation (SD)], Odds Ratio (OR), and Confidence Interval (CI). Results Eight RCTs encompassing 1,469 patients randomized to Lichtenstein repair (n = 755) and laparo-endoscopic repair (n = 714) were included. Laparo-endoscopic repair was associated with a lower likelihood of chronic inguinal pain compared to Lichtenstein repair (OR = 0.28, 95% CI [0.30–0.56], p = 0.0001). There were no significant differences in recurrence rates between the laparo-endoscopic and the Lichtenstein group (OR = 1.03, 95% CI [0.57–1.86], p = 0.92). Conclusions This systematic review and meta-analysis demonstrate that laparo-endoscopic hernia surgery leads to a lower incidence of chronic inguinal pain compared to Lichtenstein repair, while maintaining similar rates of recurrence.
- 5 June 2024
- Published by Springer Nature in Hernia
- Vol. 28 (4) , 1427-1439
Chronic inguinal pain post-hernioplasty. Laparo-endoscopic surgery vs lichtenstein repair: systematic review and meta-analysis
Purpose Annually, over 20 million patients worldwide undergo inguinal hernia repair procedures. Surgery stands as the recommended treatment, however, a consensus on the optimal method is lacking. This study aims to conduct an updated systematic review and meta-analysis to compare the risk of chronic inguinal pain and recurrence between laparo-endoscopic mesh repair (TAPP and TEP) versus Lichtenstein repair for inguinal hernia. Methods Searches were conducted in Ovid MEDLINE, PubMed, EBSCO, Cochrane, and Google Scholar. Inclusion criteria encompassed randomized controlled trials (RCTs) involving adults, published in English and Spanish, comparing surgical outcomes among the Lichtenstein open technique, TAPP, and/or TEP. Adherence to the PRISMA guidelines was maintained in the methodology, and the CASP tool was employed to assess the quality of the articles. Statistical analysis involved mean [± standard deviation (SD)], Odds Ratio (OR), and Confidence Interval (CI). Results Eight RCTs encompassing 1,469 patients randomized to Lichtenstein repair (n = 755) and laparo-endoscopic repair (n = 714) were included. Laparo-endoscopic repair was associated with a lower likelihood of chronic inguinal pain compared to Lichtenstein repair (OR = 0.28, 95% CI [0.30–0.56], p = 0.0001). There were no significant differences in recurrence rates between the laparo-endoscopic and the Lichtenstein group (OR = 1.03, 95% CI [0.57–1.86], p = 0.92). Conclusions This systematic review and meta-analysis demonstrate that laparo-endoscopic hernia surgery leads to a lower incidence of chronic inguinal pain compared to Lichtenstein repair, while maintaining similar rates of recurrence.
- 13 March 2024
- Published by Springer Nature in Hernia
- Vol. 28 (4) , 1103-1112
Long-term results with biosynthetic absorbable P4HB mesh in ventral abdominal wall repair: a multicentre analysis
Background The aim of this multicentre study was to analyse the outcomes of biosynthetic absorbable poly-4-hydroxybutyrate (P4HB) prosthesis implantation in patients undergoing ventral hernia repair (VHR) in the context of different degrees of contamination. Methods From May 2016 to December 2021, a multicentre retrospective analysis of patients who underwent elective or urgent hernia repair with P4HB prosthesis was performed in seven hospitals in Spain and Portugal. Patients with a postoperative follow-up of less than 20 months and those within the theoretical period of prosthesis resorption were excluded from the study. Regarding the degree of contamination, patients were assessed according to the modified Ventral Hernia Working Group (VHWG) classification. Epidemiological data, hernia characteristics, surgical and postoperative variables (Clavien–Dindo classification) of these patients were analyzed. Risk factors related to long-term recurrence were studied by a multivariate analysis. Results In 236 cases of P4HB prosthesis implantation, repair in cases of Grade 3 was the most frequent (49.1%), followed by Grade 2 in 42.3% of cases and Grade 1 in 8.4%. The most frequent complications were Grade 1, with the majority occurring during the first year. The overall rate of surgical site occurrences (SSO) was 30%. The hernia recurrence rate was 14.4% (n = 34), with a mean postoperative follow-up time of 41 months (22–61). The multivariate analysis showed that the onlay location of the mesh (OR 1.07; CI 1.42–2.70, p = 0.004) was a significant independent risk factor for recurrence. Conclusions The use of a P4HB bioresorbable mesh for the VHR with different degrees of contamination leads to favourable results overall, with an acceptable rate of hernia recurrence. The onlay location of the P4HB prosthesis is the main factor in recurrence in both elective and emergency settings.
- 13 March 2024
- Published by Springer Nature in Hernia
- Vol. 28 (4) , 1103-1112
Long-term results with biosynthetic absorbable P4HB mesh in ventral abdominal wall repair: a multicentre analysis
Background The aim of this multicentre study was to analyse the outcomes of biosynthetic absorbable poly-4-hydroxybutyrate (P4HB) prosthesis implantation in patients undergoing ventral hernia repair (VHR) in the context of different degrees of contamination. Methods From May 2016 to December 2021, a multicentre retrospective analysis of patients who underwent elective or urgent hernia repair with P4HB prosthesis was performed in seven hospitals in Spain and Portugal. Patients with a postoperative follow-up of less than 20 months and those within the theoretical period of prosthesis resorption were excluded from the study. Regarding the degree of contamination, patients were assessed according to the modified Ventral Hernia Working Group (VHWG) classification. Epidemiological data, hernia characteristics, surgical and postoperative variables (Clavien–Dindo classification) of these patients were analyzed. Risk factors related to long-term recurrence were studied by a multivariate analysis. Results In 236 cases of P4HB prosthesis implantation, repair in cases of Grade 3 was the most frequent (49.1%), followed by Grade 2 in 42.3% of cases and Grade 1 in 8.4%. The most frequent complications were Grade 1, with the majority occurring during the first year. The overall rate of surgical site occurrences (SSO) was 30%. The hernia recurrence rate was 14.4% (n = 34), with a mean postoperative follow-up time of 41 months (22–61). The multivariate analysis showed that the onlay location of the mesh (OR 1.07; CI 1.42–2.70, p = 0.004) was a significant independent risk factor for recurrence. Conclusions The use of a P4HB bioresorbable mesh for the VHR with different degrees of contamination leads to favourable results overall, with an acceptable rate of hernia recurrence. The onlay location of the P4HB prosthesis is the main factor in recurrence in both elective and emergency settings.